Search

Your search keyword '"Eccles D.M."' showing total 150 results

Search Constraints

Start Over You searched for: Author "Eccles D.M." Remove constraint Author: "Eccles D.M."
150 results on '"Eccles D.M."'

Search Results

2. The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective review

5. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in similar to 200,000 patients (vol 24, 69, 2022)

6. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

7. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

8. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

9. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

10. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

11. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

12. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

13. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

14. Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium.

15. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

16. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

17. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

18. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

19. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

20. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

21. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

22. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

23. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

24. Two truncating variants in FANCC and breast cancer risk.

25. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

26. Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.

27. Prediction and clinical utility of a contralateral breast cancer risk model.

28. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

29. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

30. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

31. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

32. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

33. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

34. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

35. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

36. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies

37. A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations

38. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

39. Two truncating variants in FANCC and breast cancer risk

40. Genome-wide association study of germline variants and breast cancer-specific mortality

41. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

42. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

43. Shared heritability and functional enrichment across six solid cancers.

44. Genome-wide association study of germline variants and breast cancer-specific mortality.

45. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4).

46. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

47. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

48. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

49. Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis.

50. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.

Catalog

Books, media, physical & digital resources